Knowledge of Tissue Plasminogen Activator for Acute Stroke Among Michigan Adults
Author(s) -
Beth Anderson,
Ann P. Rafferty,
Sarah Lyon-Callo,
Chris Fussman,
Mathew J. Reeves
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.545988
Subject(s) - medicine , tissue plasminogen activator , stroke (engine) , acute stroke , logistic regression , telephone survey , fibrinolytic agent , population , t plasminogen activator , thrombolysis , physical therapy , young adult , emergency medicine , gerontology , environmental health , mechanical engineering , myocardial infarction , engineering , marketing , business
Although tissue plasminogen activator (tPA) is an effective therapy for acute ischemic stroke, treatment rates remain low. Efforts to address the underuse of tPA include public education to increase the recognition of stroke symptoms and the awareness of tPA treatment. Our objective was to determine the level of knowledge about tPA treatment for acute stroke among a representative sample of Michigan adults.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom